Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.

Saved in:
Bibliographic Details
Title: Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.
Authors: Saunders AAE; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Mouchemore KA; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Vojtech L; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia., James LS; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Chadwick TB; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Chi LH; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia., Karagiannis C; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Bell C; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Thomson RE; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Parker BS; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia., Gregorevic P; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia. pgre@unimelb.edu.au.; Department of Neurology, The University of Washington School of Medicine, Seattle, WA, USA. pgre@unimelb.edu.au.; The University of Melbourne, Parkville, VIC, 3010, Australia. pgre@unimelb.edu.au.
Source: Breast cancer research : BCR [Breast Cancer Res] 2026 May 07; Vol. 28 (1). Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-542X
DOI:10.1186/s13058-026-02296-7